Translate
Kairos Pharma, Ltd.
About
0.55USD-0.01 -1.41%
Closed • Updated at 07:47 GMT+00:00Market Cap$11.67M
Volume142.7K
Beta1.80
RSI49.99
Kairos Pharma, Ltd. — investor relations, events, news, and company updates on 6ix.
Latest News
May 8 2026
Kairos Pharma, Ltd. Sets Annual Meeting of Shareholder Date and Provides Update on Its Annual Filings
Apr 15 2026
Kairos Pharma Recognized with Pinnacle Award for Excellence in Healthcare Innovation
Mar 2 2026
Kairos Pharma Announces Signing of Binding Strategic Asset Acquisition of Exclusive Worldwide Rights to CL-273 From OrbiMed and Torrey Pines Investment-Backed Celyn Therapeutics
Feb 26 2026
Kairos Pharma, Ltd. Announces Signing of Term Sheet for Strategic Asset Acquisition of Two Clinical Oncology Assets from Celyn Therapeutics
Jan 20 2026
Kairos Pharma to Present at 3rd Annual DealFlow Discovery Conference
Recent Videos
Dr. John Yu, CEO of Kairos Pharma | The Big Biz Show
Apr 21, 2026
RedChip at DealFlow Discovery: Interview with Dr. Neil Bhowmick, CSO & President of Kairos Pharma
Mar 24, 2026
Ketryx Leads AI Surge in MedTech
Feb 27, 2026
NZX Limited Reports Strong Financials; Autonomous AI Threat Highlighted; Kairos Pharma Expands On...
Feb 27, 2026
Community Chat
Ask AI
Try asking